+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

From
Antimicrobial Therapeutics Market 2024-2028 - Product Thumbnail Image

Antimicrobial Therapeutics Market 2024-2028

  • Report
  • June 2024
  • 175 Pages
  • Global
From
Ulcerative Colitis - Pipeline Review, H2 2020 - Product Thumbnail Image

Ulcerative Colitis - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 779 Pages
  • Global
From
Small Cell Lung Cancer Therapeutics Global Market Report 2024 - Product Thumbnail Image

Small Cell Lung Cancer Therapeutics Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Glioma Treatment Global Market Report 2024 - Product Thumbnail Image

Glioma Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Lung Cancer Drugs Global Market Report 2024 - Product Thumbnail Image

Lung Cancer Drugs Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
Addictions Therapeutics Global Market Report 2024 - Product Thumbnail Image

Addictions Therapeutics Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Alcohol Use Disorder - Pipeline Insight, 2024 - Product Thumbnail Image

Alcohol Use Disorder - Pipeline Insight, 2024

  • Clinical Trials
  • November 2024
  • 80 Pages
  • Global
From
From
From
From
Tachycardia (Tachyarrhythmias) - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Tachycardia (Tachyarrhythmias) - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • September 2021
  • 213 Pages
  • Global
From
Global TROP2 Antibody Market & Clinical Trials Insight 2029 - Product Thumbnail Image

Global TROP2 Antibody Market & Clinical Trials Insight 2029

  • Report
  • August 2024
  • 200 Pages
  • Global
From
Acute Myeloid Leukemia - Pipeline Insight, 2024 - Product Thumbnail Image

Acute Myeloid Leukemia - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 240 Pages
  • Global
From
From
Loading Indicator